Kinase modulation and indications therefor
US9550768B2 · kind B2 · utility
38Cited by
38References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2013 |
| Grant date | Jan 24, 2017 |
| Priority date | — |
| Expiry date | Mar 11, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, compositions and methods useful for treatment of Flt3-mediated diseases or conditions are provided herewith. Also provided herewith are methods for modulating the receptor protein tyrosine like kinase 3(Flt3).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.